Abnormal antioxidant system in inborn errors of intermediary metabolism;Alteraciones del sistema antioxidante en errores congénitos del metabolismo intermediario

Revista de Neurologia

Volumn 34, Issue 11, 2002, Pages 1021-1024

  Vilaseca Busca M A ^a,b   Artuch Iriberri, R ^a   Colome Mallolas C ^a   Brandi Tarrau, N ^a   Campistol, J ^a   Pineda Marfa M ^a   Sierra March, C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HospitalSant Joan de Dén   (Spain)

Author keywords

Antioxidant enzymes; Free radicals; Inborn errors of metabolism; Oxidative stress; Protein restricted diet; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE;

AGE; AMINOACIDOPATHY; ANALYZER; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ERYTHROCYTE; EVALUATION; GALACTOSEMIA; HOMOCYSTINURIA; HUMAN; INBORN ERROR OF METABOLISM; ORGANIC ACIDURIA; OXIDATIVE STRESS; PROTEIN RESTRICTION; PROTEIN SYNTHESIS; SPECTROMETRY; STATISTICAL SIGNIFICANCE;

EID: 0036627146     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3411.2002024     Document Type: Article

References (29)

1. Davies KJA. Oxidative stress: the paradox of aerobic life. In Rice-Evans C, Halliwell B, Lunt GG, eds. Free radicals and oxidative stress: Environment, drugs and food additives. London: Portland Press; 1995. p. 1-32.
2. Halliwell B. Free radicals, antioxidant, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-4.
3. Beal MF. Mitochondria, free radical, and neurodegeneration. Curr Opin Neurobiol 1996; 6: 661-6.
4. Heales SJR, Bolaños JP, Brand MP, Clark JB, Land JM. Mitochondrial damage: an important feature in a number of inborn errors of metabolism? J Inher Metab Dis 1996; 19: 140-2.
5. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000; 25: 502-8.
6. Colomé C, Sierra C, Vilaseca MA. Errores congénitos del metabolismo: ¿causa de estrés oxidativo? Med Clin (Barc) 2000; 115: 111-7.
7. Narasimhan P, Sklar R, Murrell M, Swanson RA, Sharp FR. Methylmalonyl-CoA mutase induction by cerebral ischemia and neurotoxicity of the mitochondrial toxin methylmalonic acid. J Neurosci 1996; 16: 7336-46.
8. +, K+-ATPase activity in cerebral cortex of rats. Neuroreport 2000; 11: 2331-4.
9. Chalmers RA. Current research in the organic acidurias. J Inher Metab Dis 1989; 12: 225-39.
10. Nakao S, Moriya Y, Furuyama S, Niederman R, Sugiya H. Propionic acid stimulates superoxide generation in human neutrophils. Cell Biol Int 1998; 22: 331-7.
11. Silva CG, Silva AR, Ruschel C, Heledga C, Wyse AT, Wannmacher CM, et al. Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats. Metab Brain Dis 2000; 15: 123-31.
12. Bird S, Miller NJ, Collins JE, Rice-Evans CA. Plasma antioxidant capacity in two cases of tirosinaemia type 1: one case treated with NTBC. J Inher Metab Dis 1995; 18: 123-6.
13. Loscalzo J. The oxidant stress of hyperhomocist(e)inemia. J Clin Invest 1996; 98: 5-7.
14. Ferguson E, Hogg N, Antholine WE, Joseph J, Singh RJ, Parthasarathy S, et al. Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: antioxidant implications. Free Radic Biol Med 1999; 26: 968-77.
15. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS. Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 2000; 279: 671-8.
16. Olszewski AJ, McCully KS. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 1993; 14: 683-93.
17. Zhang F, Slungaard A, Vercellotti GM, Iadecola C. Superoxide-dependent cerebrovascular effects of homocysteine. Am J Physiol 1998; 274: 1704-11.
18. 2 act synergistically to enhance mitochondrial damage. J Biol Chem 1998; 273: 30808-17.
19. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 2001; 50: 76-82.
20. Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 1997; 22: 587-92.
21. Bolafios JP, Heales SJR, Land JM, Clark JB. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem 1995; 64: 1965-72.
22. Sierra C, Vilaseca MA, Moyano D, Brandi N, Campistol J, et al. Antioxidant status in hyperphenylalaninemia. Clin Chim Acta 1998; 276: 1-9.
23. Artuch R, Vilaseca MA, Moreno J, Lambruschini N, Cambra FJ, Campistol J. Decreased serum ubiquinone-10 concentration in phenylketonuria. Am J Clin Nutr 1999; 70: 892-5.
24. Moyano D, Vilaseca MA, Artuch R, Pineda M, Campistol J, Vernet A, et al. Tocopherol in inborn errors of intermediary metabolism. Clin Chim Acta 1997; 263: 147-55.
25. Wilke BC, Vidailhet M, Favier A, Guillemin C, Ducros V, Amaud J, et al. Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation. Clin Chim Acta 1992; 207: 137-42.
26. Lombeck I, Kasperek K, Bachmann D, Feinendegen LE, Bremer HJ. Selenium requirements in patients with inborn errors of amino acid metabolism and selenium deficiency. Eur J Pediatr 1980; 134: 65-8.
27. Przyrembel H, Bremer HJ. Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 2000; 159 (Suppl 2): S129-35.
28. Geromel V, Kadhom N, Cebalos-Picot I, Ouari O, Polidori A, Munnich A, et al. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene ofthe mitochondrial DNA. Hum Mol Genet 2001; 10: 1221-8.
29. Rohrdanz E, Schmuck G, Ohler S, Kahl R. The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes. Brain Res 2001; 900: 128-36.